Nanobiotix (NBTX) to Release Earnings on Wednesday

Nanobiotix (NASDAQ:NBTX) is projected to issue its quarterly earnings data before the market opens on Wednesday, April 23rd. Analysts expect the company to announce earnings of ($0.58) per share and revenue of $3.55 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Nanobiotix Price Performance

NASDAQ NBTX opened at $3.41 on Wednesday. Nanobiotix has a 52-week low of $2.76 and a 52-week high of $7.51. The business’s 50-day moving average price is $3.55 and its 200 day moving average price is $3.68.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on NBTX. UBS Group upgraded Nanobiotix to a “hold” rating in a research note on Monday, February 17th. Guggenheim lowered their price objective on shares of Nanobiotix from $12.00 to $8.00 and set a “buy” rating on the stock in a research report on Friday, April 4th.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.